The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective Study.
Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Seval OrmanDepartment of Medical Oncology, Health Science University, Kartal Dr Lutfi Kırdar City Hospital, Istanbul 34865, Türkiye.ORCID 0009-0008-6771-3263
Miray AydoğanDepartment of Medical Oncology, Health Science University, Kartal Dr Lutfi Kırdar City Hospital, Istanbul 34865, Türkiye.
Oğuzcan KınıkoğluDepartment of Medical Oncology, Health Science University, Kartal Dr Lutfi Kırdar City Hospital, Istanbul 34865, Türkiye.ORCID 0000-0001-5983-3291
Sedat YıldırımDepartment of Medical Oncology, Health Science University, Kartal Dr Lutfi Kırdar City Hospital, Istanbul 34865, Türkiye.ORCID 0000-0002-2423-6902
Nisanur Sarıyar BuseryDepartment of Medical Oncology, Health Science University, Kartal Dr Lutfi Kırdar City Hospital, Istanbul 34865, Türkiye.ORCID 0000-0001-5863-3511
Hacer Şahika YıldızDepartment of Medical Oncology, Health Science University, Kartal Dr Lutfi Kırdar City Hospital, Istanbul 34865, Türkiye.
Ezgi TürkoğluDepartment of Medical Oncology, Health Science University, Kartal Dr Lutfi Kırdar City Hospital, Istanbul 34865, Türkiye.ORCID 0000-0003-3846-7047
Tuğba KayaDepartment of Medical Oncology, Health Science University, Kartal Dr Lutfi Kırdar City Hospital, Istanbul 34865, Türkiye.
Deniz IşıkDepartment of Medical Oncology, Health Science University, Kartal Dr Lutfi Kırdar City Hospital, Istanbul 34865, Türkiye.ORCID 0000-0003-4398-5148
Seval Ay ErsoyDepartment of Medical Oncology, Health Science University, Kartal Dr Lutfi Kırdar City Hospital, Istanbul 34865, Türkiye.ORCID 0000-0002-7555-2657
Hatice OdabaşDepartment of Medical Oncology, Health Science University, Kartal Dr Lutfi Kırdar City Hospital, Istanbul 34865, Türkiye.ORCID 0000-0002-5757-4705
Nedim TuranDepartment of Medical Oncology, Health Science University, Kartal Dr Lutfi Kırdar City Hospital, Istanbul 34865, Türkiye.ORCID 0000-0002-1140-8779
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective Study. · full record | OpenQuestion